381 related articles for article (PubMed ID: 32623455)
1. Lung Cancer Screening Eligibility and Utilization Among Transgender Patients: An Analysis of the 2017-2018 United States Behavioral Risk Factor Surveillance System Survey.
Stowell JT; Parikh Y; Tilson K; Narayan AK
Nicotine Tob Res; 2020 Dec; 22(12):2164-2169. PubMed ID: 32623455
[TBL] [Abstract][Full Text] [Related]
2. Breast and cervical cancer screenings across gender identity: results from the Behavioral Risk Factor Surveillance System before and during the COVID-19 pandemic.
Berzansky I; Reynolds CA; Charlton BM
Cancer Causes Control; 2024 May; 35(5):865-872. PubMed ID: 38280155
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer screening eligibility and use with low-dose computed tomography: Results from the 2018 Behavioral Risk Factor Surveillance System cross-sectional survey.
Narayan AK; Gupta Y; Little BP; Shepard JO; Flores EJ
Cancer; 2021 Mar; 127(5):748-756. PubMed ID: 33206388
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Private and Public Health Insurance Among Transgender and Gender Diverse Adults.
Downing J; Lawley KA; McDowell A
Med Care; 2022 Apr; 60(4):311-315. PubMed ID: 35180717
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity Profiles and Lung Cancer Screening among Older Adults: U.S. Behavioral Risk Factor Surveillance System 2017-2019.
Advani S; Zhang D; Tammemagi M; Akinyemiju T; Gould MK; Silvestri GA; Braithwaite D
Ann Am Thorac Soc; 2021 Nov; 18(11):1886-1893. PubMed ID: 33939595
[No Abstract] [Full Text] [Related]
7. Racial and Ethnic Disparities in Lung Cancer Screening Eligibility.
Narayan AK; Chowdhry DN; Fintelmann FJ; Little BP; Shepard JO; Flores EJ
Radiology; 2021 Dec; 301(3):712-720. PubMed ID: 34546133
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes Following Acute Residential Psychiatric Treatment in Transgender and Gender Diverse Adolescents.
Silveri MM; Schuttenberg EM; Schmandt K; Stein ER; Rieselbach MM; Sternberg A; Cohen-Gilbert JE; Katz-Wise SL; Blackford JU; Potter AS; Potter MP; Sarvey DB; McWhinnie CM; Feinberg JE; Boger KD
JAMA Netw Open; 2021 Jun; 4(6):e2113637. PubMed ID: 34152417
[TBL] [Abstract][Full Text] [Related]
9. Transgender Dependent Adolescents in the U.S. Military Health Care System: Demographics, Treatments Sought, and Health Care Service Utilization.
Van Donge N; Schvey NA; Roberts TA; Klein DA
Mil Med; 2019 May; 184(5-6):e447-e454. PubMed ID: 30325452
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
[TBL] [Abstract][Full Text] [Related]
11. Transgender individuals' cancer survivorship: Results of a cross-sectional study.
Boehmer U; Gereige J; Winter M; Ozonoff A; Scout N
Cancer; 2020 Jun; 126(12):2829-2836. PubMed ID: 32134515
[TBL] [Abstract][Full Text] [Related]
12. Alcohol and cannabis use during the COVID-19 pandemic among transgender, gender-diverse, and cisgender adults in Canada.
Somé NH; Shokoohi M; Shield KD; Wells S; Hamilton HA; Elton-Marshall T; Abramovich A
BMC Public Health; 2022 Mar; 22(1):452. PubMed ID: 35255847
[TBL] [Abstract][Full Text] [Related]
13. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation.
Japuntich SJ; Krieger NH; Salvas AL; Carey MP
J Natl Med Assoc; 2018 Oct; 110(5):424-427. PubMed ID: 30129479
[TBL] [Abstract][Full Text] [Related]
14. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
Barbosa EJM; Yang R; Hershman M
AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
[No Abstract] [Full Text] [Related]
15. Revisiting the lung cancer screening eligibility criteria to promote equity for Black individuals.
Gudina AT; Kamen C; Hardy SJ; Kehoe L; Culakova E; Cupertino AP
Lung Cancer; 2024 May; 191():107539. PubMed ID: 38552545
[TBL] [Abstract][Full Text] [Related]
16. Utilization of Lung Cancer Screening in the Medicare Fee-for-Service Population.
Tailor TD; Tong BC; Gao J; Henderson LM; Choudhury KR; Rubin GD
Chest; 2020 Nov; 158(5):2200-2210. PubMed ID: 32562612
[TBL] [Abstract][Full Text] [Related]
17. Health Care Satisfaction in Relation to Gender Identity: Behavioral Risk Factor Surveillance Survey, 20 States (2014-2018).
Ferrucci KA; Walubita T; Beccia AL; Ding EY; Jesdale BM; Lapane KL; Streed CG
Med Care; 2021 Apr; 59(4):312-318. PubMed ID: 33492048
[TBL] [Abstract][Full Text] [Related]
18. Health and health care access in the US transgender population health (TransPop) survey.
Feldman JL; Luhur WE; Herman JL; Poteat T; Meyer IH
Andrology; 2021 Nov; 9(6):1707-1718. PubMed ID: 34080788
[TBL] [Abstract][Full Text] [Related]
19. Likelihood of Lung Cancer Screening by Poor Health Status and Race and Ethnicity in US Adults, 2017 to 2020.
Rustagi AS; Byers AL; Keyhani S
JAMA Netw Open; 2022 Mar; 5(3):e225318. PubMed ID: 35357450
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and Predictors of Cardiovascular Disease and Risk Factors in Transgender Persons in the United States.
Malhotra A; Kort S; Lauther T; Mann N; Skopicki HA; Parikh PB
Crit Pathw Cardiol; 2022 Mar; 21(1):42-46. PubMed ID: 34798650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
